Clinical Trial Update: Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study assessing atomoxetine for effectiveness in children with fetal alcohol syndrome and ADHD/ADD, which has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Fetal Alcohol Syndrome

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: University of Oklahoma | Conditions: Fetal Alcohol Syndrome, Attention Deficit Disorder With Hyperactivity (ADHD) | Phase 1 | Status: COMPLETED